Connect with us

Health

Johnson & Johnson COVID-19 vaccine linked to potentially paralysing Guillain-Barré syndrome – 7NEWS.com.au

Just weeks ago, the TGA granted the vaccine provisional approval for use in Australia.

Published

on

Article feature image

There are fears some recipients of Johnson & Johnsons coronavirus vaccine face an increased risk of a rare neurological complication known as Guillain-Barre syndrome (GBS) after an increase in reports of the sometimes paralysing condition.
The US Food and…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending